USP21 negatively regulates antiviral response by acting as a RIG-I deubiquitinase by Fan, Yihui et al.
Article
The Rockefeller University Press $30.00
J. Exp. Med. 2014 Vol. 211 No. 2 313-328
www.jem.org/cgi/doi/10.1084/jem.20122844
313
The innate immune system, an evolutionarily 
conserved mechanism, is the first line of de-
fense against viral infection. The hallmark of 
antiviral innate immune response is induction 
of type I IFNs and proinflammatory cytokines 
(Yoneyama and Fujita, 2009; Takeuchi and 
Akira, 2010). Type I IFNs not only locally sup-
press viral infection and proliferation but also 
facilitate effective adaptive immune responses. 
Induction of type-I IFN is initiated by detec-
tion of viral nucleic acids through the pattern 
recognition receptor (PRRs) family, including 
TLRs, RIG-I–like receptors (RLRs), NOD-
like receptors (NLRs), and C-type lectin recep-
tors (CLRs; Akira et al., 2006). RLRs include 
RIG-I, MDA5, and LGP2, all of which contain 
a DExD-box RNA helicase domain, but only 
RIG-I and MDA5 contain N-terminal tandem 
caspase recruitment domains (CARDs) that me-
diate downstream signaling (Yoneyama et al., 
2004; Fujita, 2009). RIG-I is essential for type-I 
IFN production in mouse embryonic fibroblasts 
(MEFs), conventional dendritic cells (cDCs), and 
macrophages in response to RNA viruses such 
as Sendai virus (SeV), vesicular stomatitis virus 
(VSV), hepatitis C virus (HCV), influenza A 
CORRESPONDENCE  
Guotong Xu:  
gtxu@tongji.edu.cn  
OR  
Jianhua Yang:  
jianhuay@bcm.edu
Abbreviations used: BMDC, 
BM-derived dendritic cell; 
CARD, caspase recruitment 
domain; DUB, deubiquitinating 
enzyme; MEF, mouse embry-
onic fibroblast; PM, peritoneal 
macrophage; PRR, pattern 
recognition receptor; RLR, 
RIG-I-like receptor; SeV, Sen-
dai virus; Ub, ubiquitin; USP21, 
ubiquitin-specific peptidases 21; 
VSV, vesicular stomatitis virus.
USP21 negatively regulates antiviral 
response by acting as a RIG-I deubiquitinase
Yihui Fan,1,3 Renfang Mao,2 Yang Yu,1 Shangfeng Liu,3 Zhongcheng Shi,5 
Jin Cheng,1 Huiyuan Zhang,6 Lei An,6 Yanling Zhao,1 Xin Xu,1  
Zhenghu Chen,3 Mari Kogiso,1 Dekai Zhang,5 Hong Zhang,2,6  
Pumin Zhang,7 Jae U. Jung,8 Xiaonan Li,1 Guotong Xu,3,4 and Jianhua Yang1
1Texas Children’s Cancer Center, Department of Pediatrics, 2Department of Pathology and Immunology, Dan L. Duncan Cancer 
Center, Baylor College of Medicine, Houston, TX 77030
3Translational Center for Stem Cell Research, Tongji Hospital, Department of Regenerative Medicine; 4Department  
of Ophthalmology, Shanghai Tenth People’s Hospital, and Tongji Eye Institute, Tongji University School of Medicine, Shanghai 
200065, China
5Center for Infectious and Inflammatory Diseases at Institute of Biosciences and Technology, Texas A&M University Health 
Science Center, Houston, TX 77030
6Department of Pathology, MD Anderson Cancer Center, Houston, TX 77030
7Departments of Molecular Physiology and Biophysics, Baylor College of Medicine, Houston, TX 77030
8Department of Molecular Microbiology and Immunology, Keck School of Medicine, University of Southern California,  
Los Angeles, CA 90033
Lys63-linked polyubiquitination of RIG-I is essential in antiviral immune defense, yet the 
molecular mechanism that negatively regulates this critical step is poorly understood. Here, 
we report that USP21 acts as a novel negative regulator in antiviral responses through its 
ability to bind to and deubiquitinate RIG-I. Overexpression of USP21 inhibited RNA virus–
induced RIG-I polyubiquitination and RIG-I–mediated interferon (IFN) signaling, whereas 
deletion of USP21 resulted in elevated RIG-I polyubiquitination, IRF3 phosphorylation,  
IFN-/ production, and antiviral responses in MEFs in response to RNA virus infection. 
USP21 also restricted antiviral responses in peritoneal macrophages (PMs) and bone  
marrow–derived dendritic cells (BMDCs). USP21-deficient mice spontaneously developed 
splenomegaly and were more resistant to VSV infection with elevated production of IFNs. 
Chimeric mice with USP21-deficient hematopoietic cells developed virus-induced spleno-
megaly and were more resistant to VSV infection. Functional comparison of three deubiqui-
tinases (USP21, A20, and CYLD) demonstrated that USP21 acts as a bona fide RIG-I 
deubiquitinase to down-regulate antiviral response independent of the A20 ubiquitin-
editing complex. Our studies identify a previously unrecognized role for USP21 in the 
negative regulation of antiviral response through deubiquitinating RIG-I.
© 2014 Fan et al. This article is distributed under the terms of an Attribution– 
Noncommercial–Share Alike–No Mirror Sites license for the first six months 
after the publication date (see http://www.rupress.org/terms). After six months 
it is available under a Creative Commons License (Attribution–Noncommercial– 
Share Alike 3.0 Unported license, as described at http://creativecommons.org/ 
licenses/by-nc-sa/3.0/).
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(RIG-I-CARD)–induced IRF3 activation, IFN-/ pro-
duction, and antiviral response. Mice lacking USP21 are via-
ble and fertile, but they present splenomegaly and are more 
resistant to VSV infection with elevated IFNs production. The 
inhibitory function of USP21 in antiviral signaling is inde-
pendent of A20 ubiquitin-editing complex. Our results reveal 
the novel physiological function of USP21 in antiviral re-
sponse and highlight USP21 as a RIG-I deubiquitinase.
RESULTS
USP21 inhibits RIG-I-CARD–mediated IRF3  
activation and negatively regulates antiviral response
Lys63-linked polyubiquitination of RIG-I-CARD plays an 
essential role in RNA virus–induced IRF3 activation and 
IFN- production (Gack et al., 2007). However, the molecu-
lar mechanism of RIG-I-CARD deubiquitination is not fully 
understood. To explore whether members of the ubiquitin-
specific peptidase (USPs) subclass of DUBs are involved in 
the deubiquitination of RIG-I-CARD and down-regulation 
of RIG-I-CARD–mediated IRF3 activation, we screened a 
library of mammalian expression vectors that encode 37 USPs 
to assess the effects of overexpression of each USP on RIG-I-
CARD–induced IFN- luciferase activity. In this screening, 
USP18 and USP21 significantly inhibited RIG-I-CARD–
induced IFN- reporter activity, whereas other USPs had no 
effect or fewer effects (Fig. 1 A). USP18, an ISG15 deconju-
gating protease, has been suggested to negatively regulate anti-
viral response (Ritchie et al., 2004; Malakhova et al., 2006). 
USP21 is a highly conserved deubiquitinase and has a rela-
tively high expression in immune organs and cells (unpub-
lished data).
Next, we examined whether the deubiquitinase activity 
of USP21 is required for its inhibitory effect. Overexpression 
of USP21 WT, but not its deubiquitinase-deficient (C221A) 
mutant, blocked the SeV-, RIG-I-CARD–, and TBK1- 
induced IFN- reporter activity (unpublished data). Because 
IFN- reporter activity is dependent on both NF-B and 
IRF3 (Honda et al., 2006), we further tested the inhibitory 
effect of USP21 on SeV-, RIG-I-CARD–, and TBK1- 
induced NF-B and ISRE reporter activities. USP21 WT but 
not C221A mutant inhibited SeV-, RIG-I-CARD–, and 
TBK1-induced NF-B reporter activity (unpublished data). 
However, USP21 only inhibited SeV- and RIG-I-CARD–, 
but not TBK1-induced ISRE reporter activity (Fig. 1, B–D). 
Consistently, USP21 WT but not C221A mutant inhibited 
RIG-I-CARD– but not MAVS- or TBK1-induced IRF3 
phosphorylation (Fig. 1, E–G). Furthermore, human USP21 
inhibited SeV-induced IFN- reporter activities in MEFs 
whereas mouse USP21 inhibited SeV-induced IFN- re-
porter activities in HEK293T cells (Fig. 1 H and not de-
picted), suggesting that USP21 function in antiviral signaling 
is not limited by cell type and is conserved between human 
and mouse.
Because IRF3 activation is critical for antiviral response, 
we determined whether USP21 could inhibit antiviral response. 
Ectopic expression of USP21 WT but not C221A mutant 
virus (Flu), and Japanese encephalitis virus (JEV; Kato et al., 
2005; Kato et al., 2006). Virus-induced IFN production is 
tightly regulated to prevent persistent IFN production, which 
has been associated with a variety of immunological disorders 
(Seth et al., 2005; Moser et al., 2009; Ramos et al., 2011).
Upon binding to RNA ligands, the conformation of the 
RIG-I protein changes and then the N-terminal tandem 
CARDs trigger interaction with its downstream partner 
MAVS (Kawai et al., 2005; Meylan et al., 2005; Seth et al., 
2005; Xu et al., 2005). MAVS contains an N-terminal CARD 
that interacts with the tandem CARDs of RIG-I and a 
C-terminal trans-membrane domain that localizes it to 
the mitochondrial outer membrane. MAVS then activates 
IKK–IKK–NEMO and TBK1–IKK complexes, which in 
turn activate the transcription factors NF-B and IRF3, respec-
tively. Together with other transcription factors, NF-B and 
IRF3 induce the expression of type I IFNs and other antiviral 
cytokines (Yoneyama and Fujita, 2009; Takeuchi and Akira, 
2010). Lys63-linked polyubiquitination of RIG-I at Lys-172 
catalyzed by TRIM25 is an important step for RIG-I activa-
tion (Gack et al., 2007). Another RIG-I E3 ligase, RNF135, 
mediates Lys63-linked polyubiquitination of RIG-I at the 
C-terminal domain and is essential for RIG-I–dependent im-
mune responses (Gao et al., 2009; Oshiumi et al., 2009, 2010). 
An in vitro reconstitution system of the RIG-I pathway 
showed that unanchored Lys63-linked polyubiquitin chains 
binding to RIG-I is required for RIG-I activation (Zeng 
et al., 2010). Compared to Lys63-linked polyubiquitination-
mediated RIG-I activation, the negative regulation of Lys63-
linked polyubiquitination of RIG-I is less understood.
Ubiquitination, a reversible process, can be reversed by 
deubiquitinating enzymes (DUBs), which specifically cleave 
the isopeptide bond at the C terminus of ubiquitin (Ub; 
Komander et al., 2009). A20, an ubiquitin-editing enzyme, has 
been shown to negatively regulate antiviral pathways (Wang 
et al., 2004; Saitoh et al., 2005; Lin et al., 2006; Parvatiyar et al., 
2010). However, due to the fact that the deubiquitinase activ-
ity of A20 is not required for its inhibitory effect in antiviral 
signaling, A20 is unlikely to act as a direct RIG-I deubiquitin-
ase and the mechanism remains to be clearly defined (Lin et al., 
2006; Parvatiyar et al., 2010). Another DUB family protein, 
CYLD, has been suggested as a RIG-I deubiquitinase to neg-
atively regulate antiviral response (Friedman et al., 2008; 
Zhang et al., 2008). However, CYLD has also been shown to 
bind to and deubiquitinate TBK1 and IKK (Friedman et al., 
2008). A recent in vivo study reported that CYLD is required 
for host defense against VSV infection, suggesting the precise 
mechanism and the direct target(s) of CYLD in antiviral re-
sponse remain to be clarified (Zhang et al., 2011). Therefore, 
the authentic deubiquitinase of RIG-I remains unclear.
Using a functional genomic screening, we have identified 
USP21 as a bona fide RIG-I deubiquitinase. USP21 inhibits 
virus-induced IRF3 activation via binding to and deubiqui-
tinating RIG-I. Genetic deletion of USP21 in primary MEFs, 
peritoneal macrophages (PMs), and BM–derived dendritic 
cells (BMDCs) enhances virus- and RIG-I CARD domain 
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and failed to prevent VSV replication (unpublished data). 
These results suggest that USP21 is a novel negative regulator 
in antiviral response and very likely targets RIG-I.
blocked SeV-induced IFN- and CCL5 production (Fig. 1, 
I and J). Consistently, ectopic expression of USP21 WT but 
not C221A mutant made cells more susceptible to VSV infection 
Figure 1. USP21 inhibits RIG-I-CARD–induced IRF3 activation and IFN- signaling. (A) RIG-I-CARD was co-transfected with indicated USPs or 
control vectors along with IFN- luciferase reporter into HEK293T cells for 36 h. IFN- luciferase activity was measured and normalized with the Renilla 
activity. (B) HEK293T cells were transfected with USP21 WT or C221A (CA) mutant along with ISRE luciferase reporter vectors for 24 h, and then infected 
with SeV or left uninfected for 12 h before ISRE luciferase was measured. (C and D) RIG-I-CARD or TBK1 were co-transfected with USP21 WT or CA 
mutant along with ISRE luciferase reporter vectors into HEK293T cells for 36 h before ISRE luciferase activity was measured. (E–G) FLAG-RIG-I-CARD, 
FLAG-MAVS, or FLAG-TBK1 were co-transfected with empty vector or expression vector encoding MYC-USP21 WT or CA mutant into HEK293T cells for  
36 h. Cells lysates were immunoblotted with the indicated antibodies. (H) HEK293T cells were transfected with mouse orthologous USP21 WT or CA mutant 
along with IFN- luciferase vectors for 24 h, and then infected with SeV or left untreated for 12 h before luciferase was measured. (I and J) HEK293T cells 
were transfected with USP21 WT or CA mutant for 36 h, and then infected with SeV at the indicated time points. The mRNA level of IFN- and CCL5 was 
measured by real-time RT-PCR. Error bars indicate ±SD in duplicate experiments. Data from A is a screening data from one experiment. Data are repre-
sentative of two (H–J) or at least three (B–G) independent experiments.
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MYC-USP21 and FLAG-RIG-I-CARD proteins were also 
confirmed by immunoprecipitation with anti-FLAG anti-
bodies and immunoblotting with anti-MYC antibodies (un-
published data).
To determine whether the molecular interaction of 
USP21 and RIG-I is dependent on virus infection, we trans-
fected MYC-USP21 and FLAG-RIG-I plasmids into 
USP21 binds to and deubiquitinates RIG-I
To examine the targets of USP21 in RIG-I–mediated IRF3 
activation, we transfected MYC-USP21 into HEK293T cells 
along with FLAG-RIG-I-CARD, FLAG-MAVS, or FLAG-
TBK1. We found that MYC-USP21 proteins coimmuno-
precipitated with FLAG-RIG-I-CARD but not with FLAG- 
MAVS and FLAG-TBK1 (Fig. 2 A). The binding between 
Figure 2. USP21 binds to RIG-I and de-
ubiquitinates RIG-I. (A) HEK293T cells were 
transfected with MYC-USP21 WT or CA 
mutant along with FLAG-RIG-I-CARD, FLAG-
MAVS, or FLAG-TBK1 for 36 h. Cell lysates 
were immunoprecipitated with anti-MYC 
antibodies and immunoblotted with anti-
FLAG antibodies. (B) HEK293T cells were 
transfected with MYC-USP21 WT or CA 
mutant along with FLAG-RIG-I for 24 h, and 
then infected with SeV for the indicated time 
points. Cell lysates were immunoprecipitated 
with anti-MYC antibodies and immunoblotted 
with anti-FLAG antibodies. (C) HeLa cells were 
infected with SeV for the indicated time 
points. Endogenous USP21 in cell lysates were 
immunoprecipitated with anti-USP21 anti-
bodies and immunoblotted with anti–RIG-I 
antibodies. (D) HeLa cells were transfected 
with GFP-USP21 and FLAG-RIG-I-CARD for  
36 h, and then stained by anti-FLAG antibodies 
(red). Bar, 10 µm. (E) HeLa cells were trans-
fected with GFP-USP21 for 36 h, and then  
left uninfected or infected with SeV for 8 h. 
immunofluorescent staining was performed 
with anti–RIG-I antibodies (red). Bar, 10 µm.  
(F) HeLa cells were left uninfected or infected 
with SeV for 8 h. Immunofluorescent staining 
was performed with anti-USP21 (green) and 
anti–RIG-I (red). Bar, 10 µm. (G) FLAG- 
RIG-I-CARD and HA-Ub were co-transfected 
into HEK293T cells with control or MYC-
USP21 WT or CA mutant. Cell lysates were 
heated in the presence of 1% SDS and diluted 
with lysis buffer, and then immunoprecipi-
tated with anti-FLAG antibodies and immuno-
blotted with anti-HA antibodies. (H) HEK293T 
cells were transfected with control, MYC-
USP21 WT, or CA mutant and cell lysates were 
immunoprecipitated with anti-MYC antibod-
ies. In the parallel experiments, HEK293T cells 
were transfected with FLAG-RIG-I-CARD and 
HA-Ub. Cells were lysed in the lysis buffer 
only with PMSF. Supernatant containing poly-
ubiquitinated FLAG-RIG-I-CARD proteins were 
incubated with immunoprecipitated MYC-
USP21 WT or CA mutant for 2 h at 30°C, and 
then immunoprecipitated with anti-FLAG 
antibodies and immunoblotted with anti-HA antibodies. (I) FLAG-RIG-I and HA-Ub-K63 were co-transfected into HEK293T cells with control, MYC-USP21 
WT, or CA mutant. Transfected cells were infected with SeV for the indicated time points. Cell lysates were immunoprecipitated with anti-FLAG antibodies 
and immunoblotted with anti-HA antibodies. (J) HEK293T cells were transfected with control, MYC-USP21 WT, or CA mutant for 24 h, and then infected 
with SeV for the indicated time points. Cell lysates were immunoprecipitated with anti–RIG-I antibodies and immunoblotted with anti-Ub antibodies. 
Data are representative of two (D–F) or at least three (A–C and G–J) independent experiments.
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and ISRE reporter activities. We found that the deubiquitin-
ase activity of USP21 was required for its strong inhibitory 
effect on SeV- and RIG-I-CARD–induced IFN-, NF-B, 
and ISRE reporter activities (unpublished data). Although 
A20 strongly inhibited SeV- and RIG-I-CARD–induced 
IFN-, NF-B, and ISRE reporter activities, its deubiquitin-
ase activity was not required (unpublished data). Interestingly, the 
inhibitory effect of CYLD is relatively weaker compared with 
USP21 and A20 in these assays (unpublished data). However, 
CYLD strongly inhibited TBK1-induced ISRE reporter activity, 
whereas USP21 had no obvious effect on TBK1-induced 
ISRE reporter activity (unpublished data). These results sug-
gest USP21, A20, and CYLD use quite different mechanisms 
to regulate antiviral signaling.
To further dissect the distinct mechanism of these three 
deubiquitinases (USP21, A20, and CYLD) in antiviral signal-
ing, we compared their deubiquitinase activities and binding 
affinities to RIG-I-CARD. CYLD failed to deubiquitinate 
RIG-I-CARD both in vivo and in vitro (Fig. 3, A and B). 
Although A20 inhibited RIG-I-CARD polyubiquitination 
in vivo, it failed to do so in vitro (Fig. 3, A and B). In contrast, 
USP21 showed a much higher deubiquitinase activity to 
RIG-I-CARD both in vivo and in vitro (Fig. 3, A and B). Con-
sistently, we found USP21 but not A20 or CYLD coimmuno-
precipitated with RIG-I-CARD (Fig. 3 C). Together, these 
data suggest that USP21 is a bona fide RIG-I deubiquitinase.
USP21 inhibits TRIM25- and RNF135-mediated  
RIG-I polyubiquitination and activation
Two E3 ligases RNF135 and TRIM25 have been suggested 
to target RIG-I for Lys63-linked polyubiquitination and are 
required for antiviral response (Gack et al., 2007; Oshiumi 
et al., 2010). To uncover whether USP21 affects RNF135- 
and TRIM25-mediated RIG-I polyubiquitination and acti-
vation, we first tested the effect of USP21 on RNF135-mediated 
RIG-I activation. Overexpression of RNF135 alone could not 
induce IFN- reporter activity, whereas once co-overexpressed 
with RIG-I, RNF135 robustly induced IFN- reporter ac-
tivity, which was strongly inhibited by USP21 WT but not 
C222A mutant (Fig. 4 A and not depicted). Furthermore, 
USP21 WT but not C221A mutant also strongly inhibited 
RIG-I and RNF135-induced NF-B and ISRE reporter 
activities (unpublished data). For A20, its deubiquitinase activity 
was not required for its inhibitory effect on RNF135-mediated 
RIG-I activation (unpublished data). Moreover, USP21 de-
ubiquitinated RNF135-mediated RIG-I polyubiquitination 
both in vivo and in vitro (Fig. 4, C and D). However, CYLD 
had no significant effect on RNF135-mediated RIG-I poly-
ubiquitination, whereas A20 inhibited RNF135-mediated 
RIG-I polyubiquitination in vivo but not in vitro (Fig. 4, 
C and D).
Consistent with a previous study (Gack et al., 2007), 
TRIM25 enhanced SeV- and RIG-I–induced IFN- activ-
ity (Fig. 4 B and not depicted). USP21 inhibited TRIM25-
mediated IFN- reporter activities, which was also inhibited 
by CYLD and A20, but the deubiquitinase activity of A20 was 
HEK293T cells and treated with SeV for indicated time 
points. MYC-USP21 and FLAG-RIG-I were coimmuno-
precipitated regardless of virus infection (Fig. 2 B). To study 
the physiological function of USP21, we generated rabbit 
polyclonal antibodies against USP21. Using this antibody, we 
found that endogenous USP21 coimmunoprecipitated with 
RIG-I in HeLa cells regardless of SeV infection (Fig. 2 C). 
Consistently, transfected GFP-USP21 or endogenous USP21 
colocalized with transfected FLAG-RIG-I-CARD and en-
dogenous RIG-I regardless of SeV infection (Fig. 2, D–F). 
These results strongly suggest that USP21 binds to RIG-I.
The Lys63-linked polyubiquitination of RIG-I plays an 
essential role in virus-induced IRF3 activation (Gack et al., 
2007). We reasoned that USP21 might deubiquitinate RIG-I 
to inhibit virus-induced IRF3 activation. To test this hypoth-
esis, FLAG-RIG-I-CARD and HA-Ub plasmids were co-
transfected with control or MYC-USP21 WT or C221A 
mutant into HEK293T cells. Cell lysates were heated in the 
presence of 1% SDS and diluted with lysis buffer to disrupt non-
covalent protein–protein interactions. Overexpression of USP21 
WT but not C221A mutant abrogated FLAG-RIG-I-CARD 
polyubiquitination (Fig. 2 G). Next, we analyzed the role 
of USP21 in the deubiquitination of FLAG-RIG-I-CARD 
in vitro. Because USP21 is unstable when expressed in bacte-
ria (Ye et al., 2011) and is difficult to be purified from pro-
karyotic system, we immunoprecipitated MYC-USP21 
proteins expressed in HEK293T cells with anti-MYC anti-
bodies and then co-incubated MYC-USP21 proteins with 
cell lysates containing polyubiquitinated FLAG-RIG-I-CARD. 
The ubiquitination level of FLAG-RIG-I-CARD was signif-
icantly decreased by incubation with USP21 WT but not 
C221A mutant (Fig. 2 H). We further examined the role of 
USP21 in the inhibition of SeV-induced RIG-I polyubiqui-
tination and found that overexpression of USP21 WT but 
not C221A mutant inhibited SeV-induced polyubiquitina-
tion of both FLAG-tagged and endogenous RIG-I (Fig. 2, 
I and J). Together, our results demonstrate that USP21 acts as 
a RIG-I deubiquitinase.
The RLRs family includes three members (RIG-I, MDA5, 
and LGP2), which have been shown to mediate antiviral re-
sponse to different stimulators (Kato et al., 2006; Satoh et al., 
2010). Interestingly, we found that overexpression of USP21 
WT but not C221A mutant inhibited IFN-, NF-B, and 
ISRE reporter activities in HEK293T cells in response to 
transfected poly(I:C), which was known to be mediated by 
MDA5 (unpublished data), suggesting that USP21 might also 
target MDA5. Indeed, overexpression of USP21 WT but not 
C221A mutant inhibited Lys63-linked polyubiquitination of 
MDA5 and MDA5-mediated IFN-, NF-B, and ISRE re-
porter activities (unpublished data) and USP21 could also bind 
to MDA5 and LGP2 (unpublished data). These findings sug-
gest that USP21 also acts as a MDA5 deubiquitinase to inhibit 
MDA5-mediated antiviral response.
To further understand the functional differences of USP21, 
CYLD, and A20 in antiviral signaling, we tested their effect on 
SeV-, RIG-I-CARD–, and TBK1-induced IFN-, NF-B, 
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or survival when housed in pathogen-free condition. How-
ever, the spleens from 9 wk old USP21/ mice were sig-
nificantly larger than the ones from WT littermate controls 
(Fig. 5, E and F). The total splenocyte number was slightly 
increased in USP21/ mice (unpublished data). Flow cyto-
metric analysis of splenocytes revealed an increased percentage 
of macrophages and neutrophils in USP21/ mice (Fig. 5, 
G and H). However, the distribution of DCs, T cells and 
B cells in spleens were similar between USP21/ and WT mice 
(unpublished data). To determine whether USP21/ hema-
topoietic cells play an important role in splenomegaly devel-
opment, we transferred WT or USP21/ BM cells into SCID 
mice. Both WT and USP21/ BM cells successfully repopu-
lated in the recipient mice (Fig. 5 I). Spleens from SCID mice 
transferred with WT or USP21/ BM cells were slightly en-
larged compared with that from non-transferred mice; how-
ever, the sizes of spleens from WT and USP21/ BM transferred 
mice were comparable (Fig. 5, J–L). These data suggest that 
USP21/ hematopoietic cells are insufficient to cause sple-
nomegaly development under pathogen-free condition. No 
significant difference was observed between thymuses isolated 
from USP21/ and WT littermates (unpublished data).
To determine whether USP21 deficiency in mice affect the 
basal RIG-I protein level and IFNs production, we examined 
not required (Fig. 4 B and not depicted). These results dem-
onstrate that USP21 inhibits TRIM25- or RNF135-mediated 
RIG-I polyubiquitination and activation to negatively regu-
late antiviral signaling.
Generation of USP21 deficient mice
To further study the function of USP21 in antiviral responses, 
USP21 knockout mice were generated. We constructed the 
USP21 conditional targeting vector with which the two-loxP 
and two-frt strategy was used to obtain homologous recombi-
nation in embryonic stem (ES) cells (Fig. 5 A). USP21 het-
erozygous knockout mice were generated by breeding USP21 
conditional knockout mice with Cre transgenic mice to de-
lete USP21 exons 3 and 4, which encode part of essential 
USP domain (Fig. 5 A). Breeding of USP21 heterozygous 
male and female mice gave rise to a litter of mice with WT 
(+/+), heterozygous (+/), and homozygous (/) genotypes 
with a Mendel ratio, suggesting that USP21/ mice are via-
ble (Fig. 5 B). RT-PCR and immunoblotting analysis of 
USP21 expression in MEFs showed that endogenous WT 
USP21 transcription and protein expression were abolished 
in USP21/ mice (Fig. 5, C and D).
USP21/ mice are viable and fertile. The young 
USP21/ mice (4 wk old) showed no gross defects in growth 
Figure 3. USP21 but not A20 and CYLD 
binds to and deubiquitinates RIG-I-CARD.  
(A) FLAG-RIG-I-CARD and HA-Ub were co- 
transfected with MYC-USP21 WT, CA mutant, MYC-
CYLD, or MYC-A20. The heated cell lysates were 
immunoprecipitated with anti-FLAG antibodies 
and immunoblotted with anti-HA antibodies. 
(B) HEK293T cells were transfected with MYC-
USP21 WT, CA mutant, MYC-CYLD, or MYC-A20. 
MYC-tagged proteins were immunoprecipitated 
with anti-MYC antibodies. Supernatant contain-
ing polyubiquitinated FLAG-RIG-I-CARD proteins 
were co-incubated with the immunoprecipitated 
MYC-tagged proteins for 2 h at 30°C, and then 
immunoprecipitated with anti-FLAG antibodies 
and immunoblotted with anti-HA antibodies. 
(C) FLAG-RIG-I-CARD was co-transfected into 
HEK293T cells with control, MYC-USP21 WT,  
CA mutant, MYC-CYLD, or MYC-A20. Cell lysates 
were immunoprecipitated with anti-MYC anti-
bodies and immunoblotted with anti-FLAG anti-
bodies. Data from A–C are representative of three 
independent experiments.
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with these results, VSV and SeV induced a stronger IRF3 
phosphorylation in USP21/ MEFs compared with that in 
WT MEFs (Fig. 6 E). SeV also induced a stronger IKK/ 
phosphorylation in USP21/ MEFs compared with that in 
WT MEFs (Fig. 6 E). Furthermore, SeV replication was sig-
nificantly inhibited in USP21/ MEFs (Fig. 6 F). Consis-
tently, endogenous USP21 and RIG-I coimmunoprecipitated 
in MEFs (Fig. 6 G) and SeV induced a stronger RIG-I poly-
ubiquitination in USP21/ MEFs compared with that in 
WT MEFs (Fig. 6 H).
Furthermore, SeV induced a stronger IRF3 phosphory-
lation in USP21/ PMs compared with that in WT PMs 
(Fig. 7 A). SeV induced much more IFN-/ production in 
USP21/ PMs compared with that in WT PMs (Fig. 7, 
B and C). SeV also induced a stronger IRF3 phosphorylation 
and much more IFN-/ productions in USP21/ BMDCs 
compared with that in WT BMDCs (Fig. 7, D–F). However, 
we could not observe any significant effect of USP21 deficiency 
on SeV-induced IRF3 phosphorylation, IFN-/ produc-
tion in BM-derived macrophages (BMMs; unpublished data). 
It is noteworthy that USP21 expression level was much lower 
in BMMs compared with MEFs, BMDCs, and PMs (unpub-
lished data).
RIG-I protein level in multiple organs and no significant dif-
ference was found between 9-wk-old WT and USP21/ 
mice (Fig. 5 O). The basal RIG-I protein level in BMDCs 
and PMs was also comparable between WT and USP21/ 
mice (Fig. 5 M). Basal IFN-/ production in 9-wk-old 
USP21/ mice is similar to that in WT mice (Fig. 5 N). Our 
results suggested that deletion of USP21 in mice did not 
affect the basal RIG-I expression and IFNs production in 
9-wk-old USP21/ mice with noticeable splenomegaly.
Deletion of USP21 enhances antiviral  
response in multiple cell types
To further assess the physiological function of USP21, we iso-
lated MEFs from WT and USP21/ embryos. SeV infection, 
transfection of poly(I:C), and RIG-I-CARD overexpression 
resulted in higher IFN- and ISRE reporter activities in 
USP21/ MEFs compared with that in WT MEFs (Fig. 6 A). 
Consistently, virus-induced IFN- and - expressions were 
much higher in USP21/ MEFs compared with WT MEFs 
(Fig. 6 B). Upon infection with VSV-eGFP, USP21/ MEFs 
showed significantly decreased number of VSV-eGFP+ cells 
(Fig. 6 C). USP21/ MEFs were also more resistant to VSV 
infection compared with WT MEFs (Fig. 6 D). Consistent 
Figure 4. USP21 inhibits TRIM25- and 
RNF135-induced RIG-I activation. (A) HEK293T 
cells were transfected with indicated plasmids for 
24 h, and then left uninfected or infected with 
SeV for 12 h before IFN- luciferase activity was 
measured. (B) HEK293T cells were transfected 
with MYC-USP21 WT, CA mutant, MYC-CYLD, or 
MYC-A20 along TRIM25. Transfected cells were 
left uninfected or infected with SeV for 12 h be-
fore IFN- luciferase activity was measured. 
(C) Expression vector encoding FLAG-RIG-I, 
RNF135, and HA-Ub were co-transfected with 
control, MYC-USP21 WT, CA mutant, MYC-CYLD, 
or MYC-A20. Cell lysates were immunoprecipi-
tated with anti-FLAG antibodies and immuno-
blotted with anti-HA antibodies. (D) HEK293T cells 
were transfected with expression vectors encod-
ing MYC-USP21 WT, CA mutant, MYC-CYLD, or 
MYC-A20. MYC-tagged proteins were immuno-
precipitated with anti-MYC antibodies. In the 
parallel experiments, HEK293T cells were trans-
fected with FLAG-RIG-I, RNF135, and HA-Ub. 
Supernatant containing polyubiquitinated  
FLAG-RIG-I proteins were incubated with immuno-
precipitated MYC-USP21 WT, CA mutant, MYC-
CYLD, or MYC-A20 for 2 h at 30°C, and then 
immunoprecipitated with anti-FLAG antibodies 
and immunoblotted with anti-HA antibodies. 
Error bars indicate ±SD in duplicate experiments. 
Data are representative of two (A and B) or three 
(C and D) independent experiments.
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that USP21 function in antiviral response is independent of 
A20 ubiquitin-editing complex. Next, we examined whether 
USP21 and A20 can cooperatively inhibit antiviral signaling. 
Both USP21 and A20 inhibited SeV- and RIG-I-CARD– 
induced IFN- reporter activity in a dose-dependent manner. 
The inhibitory effect of co-overexpression of USP21 and A20 
was much stronger than individual expression of USP21 or 
A20 (Fig. 8 E and not depicted).
Recently, A20 has been suggested to inhibit TNF-induced 
NF-B activation by promoting Ubc13 and UbcH5C degra-
dation or disrupting Ubc13 or UbcH5C binding with E3 
USP21 inhibits antiviral response independent  
of A20 ubiquitin editing complex
Because A20 has been suggested to negatively regulate anti-
viral response (Lin et al., 2006; Parvatiyar et al., 2010; Saitoh 
et al., 2005; Wang et al., 2004), we next determined whether 
the inhibitory function of USP21 is dependent on A20 ubiq-
uitin-editing complex. USP21 inhibited SeV-induced IFN- 
reporter activity in WT, A20/, ITCH/, and TAXBP1/ 
MEFs (Fig. 8, A–D). USP21 also inhibited RIG-I-CARD–
induced IFN- reporter activity in WT, A20/, ITCH/, and 
TAXBP1/ MEFs (unpublished data). These results indicate 
Figure 5. Generation of USP21 knockout 
mice. (A) Generation of USP21 conditional 
knockout mice by two-loxP, two-frt strategy. 
(B) PCR genotyping of WT and USP21/ litter-
mates generated from USP21+/ mice inter-
crossing. (C) Total RNA was extracted from 
MEFs and mRNA level of USP21 was examined 
by RT-PCR. (D) Cell lysates from WT and 
USP21/ MEFs were immunoblotted by anti-
USP21 antibodies. (E) Representative images 
of spleens isolated from 9-wk WT and 
USP21/ mice. (F) Quantitative analysis of 
the weight of spleens isolated from 9-wk-old 
WT (n = 10) and USP21/ (n = 10) mice. 
(G) Macrophage and dendritic cell popula-
tions in splenocytes from USP21/ and WT 
mice were analyzed by FACS using anti-
CD11b and anti-CD11c antibodies. (H) Neu-
trophil populations in splenocytes from 
USP21/ and WT mice were analyzed by 
FACS using anti-Gr1 and anti-CD11b antibod-
ies. (I) SCID mice were transferred with WT or 
USP21/ BM cells for 10 wk. T cell popula-
tions in splenocytes were analyzed by FACS 
using anti–mouse CD3, CD4, and CD8 anti-
bodies. (J) Representative images of spleens 
from naive and BM-transferred SCID mice.  
(K) Spleens from naive and BM transferred 
SCID mice were homogenized. Total spleno-
cytes were quantitatively analyzed. (L) Quanti-
tative analysis of the weight of spleens 
isolated from naive and BM-transferred SCID 
mice. (M) Fresh BM cells were cultured in the 
medium with IL-4 and GM-CSF cytokines  
for 7 d. Cell lysates from BMDCs or PMs were 
immunoblotted by anti–RIG-I antibodies.  
(N) Blood was collected from 9-wk-old WT  
or USP21/ mice, and IFN level in sera was 
measured by ELISA kit. (O) Cells from different 
organs were lysed and immunoblotted by 
anti–RIG-I antibodies. Error bars indicate ±SD 
in duplicate experiments. ***, P < 0.001 (two-
tailed paired Student’s t test). Data are repre-
sentative of two (E–O) or at least three (B–D)  
independent experiments.
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A20 deficiency on SeV-induced IRF3 phosphorylation. Sur-
prisingly, SeV failed to induce IRF3 phosphorylation at ear-
lier time points in A20/ MEFs (Fig. 8 F). However, at later 
time points, we did see a weak induction of IRF3 phosphory-
lation (unpublished data). To further confirm the result, we 
tested the sensitivity of WT and A20/ MEF to VSV infec-
tion and found that A20/ MEFs were more sensitive com-
pared with WT MEFs (unpublished data). Consistently, SeV 
failed to induce IFN-/ production in A20/ MEFs (Fig. 8 G 
and not depicted), although IL-6 expression was comparably 
induced in both USP21/ and A20/ MEFs (unpublished 
data). These results indicate that the physiological role of A20 
in antiviral response is very complicated and its function in 
antiviral response needs to be further investigated.
ligase (Shembade et al., 2010). Thus, we examined whether 
A20 inhibits antiviral response via the aforementioned mech-
anism. Overexpression of USP21, CYLD, and A20 failed to 
promote Ubc13 and UbcH5C degradation regardless of SeV 
treatment (unpublished data). Consistently, no significant dif-
ference was found in terms of UbcH5C degradation in re-
sponse to SeV infection in WT, USP21/, and A20/ MEFs 
in the time course examined (unpublished data).
The fact that SeV induced weaker IFN- reporter activ-
ity in A20/ MEFs compared with WT, ITCH/, and 
TAXBP1/ MEFs suggests that the role of A20 in antiviral 
response is far to be fully understood (Fig. 8, A–D). To better 
understand the role of A20 in antiviral response, we infected 
WT and A20/ MEFs with SeV and examined the effect of 
Figure 6. Knockout of USP21 expression 
enhances antiviral response in MEFs.  
(A) WT and USP21/ MEFs were transfected 
with IFN- or ISRE reporter along with or with-
out RIG-I-CARD for 24 h, and then left unin-
fected or infected with SeV or transfected with 
poly (I:C) for 12 h before luciferase activity was 
measured. (B) MEFs were treated with SeV for 
the indicated time points. The mRNA levels of 
IFN-/ were measured by real-time RT-PCR. 
(C) MEFs were infected with VSV-eGFP (moi = 0.1) 
for 48 h and GFP+ cells were imaged. Bar,  
50 µm. (D) MEFs were infected with VSV for 
the indicated MOI for 48 h and relative cell 
viability was measured by CCK8 kit. (E) MEFs 
were infected with VSV or SeV for the time 
points indicated. Cell lysates were immuno-
blotted by anti–p-IRF3, anti-IRF3, anti-USP21, 
anti–p-IKK/, anti-IKK, and anti–-actin 
antibodies. (F) MEFs were infected with SeV 
for the indicated time points. Cell lysates were 
immunoblotted by anti-SeV antibodies.  
(G) MEFs were infected with SeV for the indi-
cated time points. Endogenous USP21 were 
immunoprecipitated with anti-USP21 anti-
bodies and immunoblotted with anti–RIG-I 
antibodies. (H) MEFs were infected with SeV 
for the indicated time points. RIG-I proteins in 
the cell lysates were immunoprecipitated with 
anti–RIG-I antibodies and immunoblotted 
with anti-Ub antibodies. Error bars indicate 
±SD in duplicate experiments. Data are repre-
sentative of two (B–D and F) or three (A, E, G, 
and H) independent experiments.
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compared with that in WT mice (Fig. 9 L). 4-wk-old USP21/ 
mice did not show noticeable splenomegaly and basal RIG-I 
expression in 4-wk old WT and USP21/ mice was compa-
rable (unpublished data). Intraperitoneal injection of VSV in 
4-wk-old USP21/ also induced a stronger IFN production 
compared with that in 4-wk-old WT mice (unpublished 
data). Collectively, our data indicate that USP21 negatively reg-
ulates antiviral response in vivo and the hyper-responsiveness 
of USP21-deficient mice to VSV is not due to splenomegaly 
or increased basal RIG-I expression.
DISCUSSION
Excessive production of IFNs or proinflammatory cytokines 
is destructive to hosts, thus a successful immune response 
against viral infections must be tightly regulated. Lys63-linked 
polyubiquitination of RIG-I is a pivotal event in RIG-I– 
mediated antiviral response. USP21 is a highly conserved 
deubiquitinase and its physiological role is largely unknown. 
Biochemical study and crystal structure showed that USP21 
is a highly active deubiquitinating enzyme that can efficiently 
cleave Lys63-linked ubiquitin chain (Nakagawa et al., 2008; 
Xu et al., 2010; Ye et al., 2011; García-Santisteban et al., 2012; 
Urbé et al., 2012). In this study, we present biochemical and 
genetic evidences that USP21 acts as a RIG-I deubiquitinase 
to negatively regulate RIG-I–mediated antiviral signaling 
through its deubiquitinase activity. The inhibitory effect of 
USP21 on antiviral signaling is independent of A20 ubiquitin- 
editing complex. USP21 inhibits RNA virus-induced Lys63-
linked polyubiquitination of RIG-I and RIG-I–mediated 
downstream signaling. Genetic deletion of USP21 gene in 
mice enhances RIG-I–mediated antiviral response. Further-
more, we also found that USP21 binds to two other RLR 
family members (MDA5 and LGP2) and deubiquitinates 
MDA5, suggesting USP21 acts as a major negative regulator 
Deletion of USP21 enhances antiviral  
immune defense in vivo
To investigate the role of USP21 in vivo, WT and USP21/ 
mice were injected with VSV through tail vein, and then sera 
were collected to measure type-I IFN level. We found that tail 
vein injection of VSV induced a stronger production of IFNs 
in USP21/ mice compared with that in WT mice, whereas 
the steady-state levels of IFNs without VSV infection were 
similarly very low in both WT and USP21/ mice (Fig. 9, 
A and B). Consistently, the viral titers in sera were much 
lower in USP21/ mice than those in WT mice at all time 
points examined (Fig. 9 C). USP21 deficiency did not affect 
VSV entry into the MEFs and mice organs (unpublished data). 
These results suggest that USP21 deficiency enhances viral 
clearance caused by a higher level of type-I IFN induction.
To determine whether USP21 deficiency affects the sur-
vival of mice after VSV infection, mice were infected with 
VSV through tail vein and their survival was monitored. We 
found that USP21/ mice were more resistant to VSV- 
induced lethality (Fig. 9 D). At day 8 after infection, 40% of 
WT mice died, whereas no USP21/ mice died until day 10. 
After 2 wk of VSV infection, splenomegaly in USP21/ 
mice was even more severe than that in naive mice (Fig. 9, 
E and F). SCID mice transferred with USP21/ BM cells 
developed splenomegaly after VSV infection and were resis-
tant to VSV-induced lethality (Fig. 9, G-I). These results sug-
gest that USP21/ hematopoietic cells are sufficient to cause 
splenomegaly development in mice infected with VSV and 
protect mice from VSV-induced lethality.
Consistent with the results obtained by intravenous VSV 
infection, intraperitoneal injection of VSV also induced a 
stronger production of IFNs in USP21/ mice compared 
with that in WT mice (Fig. 9, J and K). Virus titer detected in 
different organs of USP21/ mice was significantly lower 
Figure 7. Knockout of USP21 expression enhances antiviral response in PMs and BMDCs. (A) PMs isolated from WT and USP21/ mice were 
infected by SeV with the indicated time points. Cell lysates were immunoblotted by anti–p-IRF3 and anti-IRF3 antibodies. (B and C) PMs were infected by 
SeV with the indicated time points. IFN- (B) and IFN- (C) production in cell culture medium were measured by ELISA kit. (D) BMDCs were infected by 
SeV with the indicated time points. Cell lysates were immunoblotted by anti–p-IRF3 and anti-IRF3 antibodies. (E and F) BMDCs were infected by SeV with 
the indicated time points. IFN- (E) and IFN- (F) production in cell culture medium was measured by ELISA kit. Error bars indicate ±SD in duplicate ex-
periments. Data from A–F are representatives of two independent experiments.
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ligases and DUBs. Two E3 ligases, TRIM25 and RNF135, 
have been reported to catalyze Lys63-linked polyubiquitina-
tion of RIG-I and are essential for antiviral response (Gack 
et al., 2007, 2008; Oshiumi et al., 2009, 2010). However, the 
molecular mechanisms of TRIM25 and RNF135 function 
in antiviral signaling are different. Unlike TRIM25, RNF135 
alone is sufficient to polyubiquitinate and activate RIG-I 
(Fig. 4 and not depicted). It has been shown that TRIM25 
and RNF135 catalyze RIG-I polyubiquitination on different 
domains (Gack et al., 2007; Oshiumi et al., 2009). Inter-
estingly, USP21 inhibits both TRIM25- and RNF135- 
mediated antiviral response and RIG-I activation (Fig. 4 and 
not depicted). Therefore, it is highly likely that USP21 acts 
to restrict RLR-mediated antiviral responses through de-
ubiquitinating RIG-I and MDA5.
Ubiquitin can be covalently attached to other proteins 
through a stepwise enzymatic reaction involving three classes 
of enzymes (E1, E2, and E3). In addition, ubiquitination can 
be reversed by DUBs that comprise a large family of proteins 
(Nijman et al., 2005). Both ubiquitination and deubiquitina-
tion play regulatory roles in a broad spectrum of cellular pro-
cesses, including immune response (Bhoj and Chen, 2009; 
Wertz and Dixit, 2010). In the process of ubiquitination and 
deubiquitination, E3 ligases and DUBs recognize the sub-
strates and primarily determine the substrate specificity, which 
attract much effort for identification of substrate-specific E3 
Figure 8. USP21 negatively regulates antiviral response independent of A20 ubiquitin-editing complex. (A–D) WT, A20/, ITCH/, and 
TAXBP1/ MEFs were transfected with IFN- reporter along with MYC-USP21 WT or CA mutant for 24 h, and then left uninfected or infected with SeV 
for 12 h before luciferase activity was measured. (E) HEK293T cells were transfected with the indicated plasmids along with IFN- luciferase reporter for 
24 h, and then infected with SeV or left untreated for 12 h before luciferase assays were performed. (F) WT, USP21/, and A20/ MEFs were infected 
with SeV with the indicated time points. Cell lysates were immunoblotted by the indicated antibodies. (G) WT, USP21/, and A20/ MEFs were infected 
with SeV with the indicated time points. IFN- production was determined by ELISA kit. Error bars indicate ±SD in duplicate experiments. The data from 
A–G are representative of two independent experiments.
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Figure 9. Knockout of USP21 expression enhances antiviral response in vivo. (A and B) WT and USP21/ mice were injected with VSV (1 × 108 pfu) 
via tail vein for the indicated time period. Amounts of IFN- and IFN- in sera were measured by ELISA. (C) WT and USP21/ mice were infected with 
VSV (1 × 108 pfu) via tail vein injection. Sera collected at the indicated time points were used for measurement of viral titers by plaque assays. (D) WT (n = 18) 
and USP21/ (n = 18) mice were infected with VSV (2 × 108 pfu) via tail vein injection and the survival of the mice was monitored for 2 wk.  
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whereas at the high protein level, it may inhibit antiviral re-
sponse. However, the precise molecular mechanism of A20 in 
antiviral response remains to be further determined.
Another deubiquitinase, CYLD, has been suggested to 
deubiquitinate RIG-I (Friedman et al., 2008; Zhang et al., 
2008). CYLD also binds to TBK1 and CYLD/ DCs show 
constitutive activation of TBK1 (Friedman et al., 2008; Zhang 
et al., 2008). Consistent with these previous studies, CYLD 
strongly inhibits TBK1-induced ISRE reporter activity (un-
published data). However, CYLD fails to inhibit and deubiq-
uitinate RIG-I-CARD overexpression-induced RIG-CARD 
polyubiquitination both in vivo and in vitro (Fig. 3). Together, 
these results suggest that CYLD targets TBK1 or its down-
stream molecules to negatively regulate antiviral response. 
More interestingly, a recent study showed loss of CYLD ren-
ders mice considerably more susceptible to VSV infection 
(Zhang et al., 2011). Therefore, the physiological role and 
the true targets of CYLD in antiviral response need to be fur-
ther investigated.
USP21/ mice develop splenomegaly and have an in-
creased percentage of macrophages in spleen. USP21 negatively 
regulates antiviral responses in PMs and BMDCs. However, 
we did not observe any significant effect of USP21 deficiency 
on antiviral response in BMMs in vitro. It is noteworthy that 
USP21 expression level is much lower in BMMs compared 
with that in MEFs, BMDCs, and PMs (unpublished data). It 
is very likely that USP21 expression is suppressed in the 
BMMs under in vitro culture condition. Although USP21/ 
hematopoietic cells are insufficient to cause splenomegaly de-
velopment under pathogen-free conditions, they are sufficient 
to cause splenomegaly development in recipient mice in-
fected with VSV and to protect mice from VSV-induced le-
thality. These results strongly suggest that hematopoietic cells 
contribute significantly to USP21-mediated negative regula-
tion of antiviral response.
Deubiquitination is a common mechanism used by hosts to 
tightly regulate the antiviral response. In addition to USP21, 
A20, and CYLD, DUBA has been shown to down-regulate 
antiviral signaling by deubiquitinating TRAF3 (Kayagaki et al., 
2007). To our knowledge, only few deubiquitinases have been 
studied in knockout mouse model to explore their physiological 
functions in different biological processes, especially in antiviral 
response. USP21 is unique because its deubiquitinase activity is 
required for its function and USP21-deficient mice spontane-
ously develop splenomegaly and are resistant to VSV infection. 
as a RIG-I polyubiquitination guard to prevent extensive 
RIG-I polyubiquitination.
A20 contains one N-terminal deubiquitinase domain and 
seven C-terminal zinc-finger (ZnF) domains, and it plays a 
key role in the negative regulation of inflammation and 
immunity. A20 has been shown to turn off TNF-induced 
NF-B activation by modulating both Lys48- and Lys63-
linked polyubiquitin chains (Wertz et al., 2004). Induction of 
Lys48 polyubiquitination by A20 requires its C-terminal 
ZnFs ubiquitin-binding domain, which may promote inter-
action with E3 ligases (Itch and RNF11; Shembade et al., 
2007, 2008, 2009). A20 is thought to promote deubiquitina-
tion of Lys63-linked polyubiquitin chains either directly 
through its N-terminal deubiquitinase domain or by disrupt-
ing the interaction between E3 and E2 enzymes (Shembade 
et al., 2010). Interestingly, in our in vitro assay, USP21 de-
ubiquitinates RIG-I-CARD, whereas A20 fails to do so, 
even though both USP21 and A20 inhibit RIG-I-CARD 
overexpression-induced RIG-I-CARD polyubiquitination 
in vivo (Fig. 3). Furthermore, polyubiquitinated RIG-I medi-
ated by RNF135 can be deubiquitinated by USP21 but not 
A20 in vitro even though both USP21 and A20 inhibit 
RNF135-induced RIG-I polyubiquitination in vivo (Fig. 4). 
In addition, RIG-I-CARD co-immunoprecipitates with 
USP21 but not with A20 (Fig. 3 C). These results suggest that 
A20 blocks the polyubiquitination of RIG-I in vivo not by 
acting as a direct RIG-I deubiquitinase.
Ubc13 and UbcH5C play essential roles in TNF-induced 
NF-B activation and RIG-I–mediated antiviral signaling 
(Xia et al., 2009; Yamazaki et al., 2009; Zeng et al., 2009; Zeng 
et al., 2010). In TNF-induced signaling, A20 inhibits TNF- 
induced NF-B activation by promoting Ubc13 and Ub-
cH5C degradation (Shembade et al., 2010). However, unlike 
in TNF signaling, SeV fails to induce Ubc13 and UbcH5C 
degradation in the tested time courses (unpublished data). 
Surprisingly, opposite to overexpression data, SeV fails to 
induce antiviral response at the earlier time course in A20/ 
MEFs and A20/ MEFs are more sensitive to VSV-induced 
cell death compared with WT MEF (Fig. 8 and not depicted). 
Therefore, the physiological role of A20 in antiviral response 
is more complicated than what we have expected from A20 
overexpression data. It may both positively and negatively 
regulate antiviral response and its function in antiviral signal-
ing may be determined by its protein level in cells. At the low 
protein level, A20 may be essential for antiviral response, 
(E) Representative images of spleens isolated from WT and USP21/ mice 2 wk after intravenous VSV (2 × 108 pfu) infection. (F) Quantitative analysis of 
the weight of spleens isolated from 9-wk-old WT (n = 5) and USP21/ (n = 5) mice 2 wk after intravenous VSV (2 × 108 pfu) infection. (G and H) SCID 
mice were transferred with WT and USP21/ BM cells and infected with VSV (1 × 107 pfu) for 2 wk. Representative spleens (G) were shown and spleen 
weight (H) was measured. (I) SCID mice transferred with WT and USP21/ BM cells were infected with VSV (5 × 107 pfu) via tail vein injection and the 
survival of the mice was monitored for 2 wk. (J and K) WT and USP21/ mice were injected intraperitoneally with VSV (2 × 106 pfu) for the indicated 
time courses. Amount of IFN- (J) and IFN- (K) in sera was measured by ELISA. (L) WT and USP21/ mice were injected with VSV (1 × 108 pfu) through 
tail vein for the indicated time points. Mice were sacrificed and viral titers in organs were determined by the plaque assay. Error bars indicate ±SD in  
duplicate experiments. *, P < 0.05; **, P < 0.01; ***, P < 0.001 (two-tailed paired Student’s t test or Kaplan Meier survival analysis). Data are representative 
of two (A–C and E–L) or at least three (D) independent experiments.
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from Invitrogen. Anti-UbcH5C antibodies (ab106315) were obtained from 
Abcam. Anti–mouse CD16/32 (101301) antibodies were obtained from Bio-
Legend. Pacific Blue–labeled anti-CD3 (558214), APC-Cy7–labeled anti-
CD8 (561967), PE-labeled anti-CD4 (553652), APC-labeled anti–Gr-1 
(561083), PerCP-Cy5.5–labeled anti-CD11b (561114), PE-labeled anti-
CD11c (561044), APC-labeled anti-B220 (561880), FITC-labeled anti-
CD21/35 (561769), and PE-labeled anti-IgM (562033) were purchased from 
BD. Anti-USP21 antibodies were generated by immunizing rabbits with the 
synthetic peptides corresponding to amino acids MPQASEHRLGRTREPP, 
RLALRPEPPTLRRSTSLR, NAPVCDRCRQKTRSTKKLTV (Genemed 
Synthesis, Inc.). Cell culture medium was obtained from Invitrogen. Nitro-
cellulose membrane was purchased from Bio-Rad.
Constructs. The NF-B–dependent firefly luciferase reporter plasmid and 
pCMV promoter-dependent Renilla luciferase reporter plasmids were pur-
chased from Takara Bio Inc. ISRE luciferase reporter plasmid was provided 
by R. Wang (The Methodist Hospital Research Institute, Houston, TX). 
IFN- luciferase reporter plasmid was provided by D. Thanos (Academy of 
Athens, Athens, Greece). FLAG-RIG-I and FLAG-RIG-I-CARD were pro-
vided by C. Basler. FLAG-MAVS was provided by K. Li (University of 
Tennessee, Memphis, TN). FLAG-TBK1 was provided by S. Sun (MD Anderson 
Cancer Center, Houston, TX). FLAG-A20 WT, FLAG-A20 C103A mutant, 
and FLAG-A20 ZnF4 mutant were provided by C. Vincenz (University of 
Michigan, Ann Arbor, MI) and E.W. Harhaj (Johns Hopkins School of Medi-
cine), HA-TRIM25 was purchased from Addgene Inc. 37 human USPs 
cDNA clones were purchased from Open Biosystems Company and sub-
cloned into pcDNA3.1 expression vector (Invitrogen, CA) as described pre-
viously (Fan et al., 2011). Mammalian expression vectors for USP21 WT and 
C221A mutant with or without an N-terminal MYC or FLAG tag were de-
scribed previously (Xu et al., 2010). Expression vectors for CYLD and A20 
were described previously (Fan et al., 2011).
Transfection and reporter gene assays. HEK293T cells and MEF cells 
were transfected with expression plasmids using FuGene 6 (Roche) or Lipo-
fectamine 2000 respectively (Invitrogen). Reporter gene assays were per-
formed as described previously (Fan et al., 2010). In brief, targeted cells were 
seeded at a concentration of 3 × 105 cells per well and cultured overnight in 
6-well plates. The cells were transfected with the indicated plasmids, together 
with IFN-, ISRE, NF-B–dependent firefly luciferase construct and Renilla 
luciferase construct.
Immunoblot analysis, coimmunoprecipitation, and quantitative 
RT-PCR. These experiments were performed as previously described (Fan 
et al., 2010). In brief, targeted cells were lysed in lysate buffer (25 mM Tris-HCl, 
pH 7.4, 150 mM NaCl, 1 mM EDTA, 1% NP-40 and 5% glycerol, 1 mM 
PMSF, 1 mM DTT, 10 µg/ml aprotinin, 10 µg/ml leupeptin, 1 mM benzami-
dine, and phosphatase inhibitor cocktail A and B). After centrifuging cell ly-
sate at 15,000 g for 15 min at 4°C, primary antibodies were added to the 
supernatant and incubated with rotation for 3 h at 4°C. After adding a pro-
tein A–agarose bead suspension, the mixture was further incubated with rota-
tion for 3 h at 4°C. The precipitates were washed three times using precold 
washing buffer (20 mM Hepes, pH 7.7, 50 mM NaCl, 2.5 mM MgCl2, 
0.1 mM EDTA, and 0.05% Triton X-100), and then the beads were resus-
pended in Laemmli sample buffer and boiled for 10 min. For RT-PCR, cells 
were collected using TRIzol (Invitrogen) and RNA extracted according to 
manufacturer’s protocol. Quantitative real-time PCR was performed using 
KAPA SYBR FAST Universal one-Step qRT-PCR kit (ABgene) and ana-
lyzed by Applied Biosystems 7300 real-time PCR system. Data were normal-
ized to housekeeping GAPDH or 18S gene and the relative abundance of 
the transcripts was calculated by the Ct models.
Immunofluorescent confocal microscopy. Cells were grown on Cham-
ber slide, and uninfected or infected with SeV for 8 h. Treated cells were fixed 
in 4% paraformaldehyde for 15 min, permeabilized by 0.2% Triton X-100, 
and then blocked with 1% BSA for 45 min. Primarily antibodies were incu-
bated overnight at 4°C. After washing three times, the cells were probed with 
Inhibition of USP21 deubiquitinase activity may enhance an-
tiviral response and could be beneficial to certain patients with 
low immune activity.
MATERIALS AND METHODS
Generation of USP21-deficient mice. We constructed the USP21- 
conditional targeting vector with which the two-loxP and two-frt strategy was 
used to delete the exon 3 and 4 that encodes part of essential USP21 USP do-
main. Homologous recombination in mouse ES cells and blastocyst injection of 
ES cells were performed at the Baylor College of Medicine core facility. 
USP21+/flox-frt-neo mice were crossed with Meox2-Cre mice to generate 
USP21+/ mice with deletion of exon 3 and 4, and reading frame shift was me-
diated by loxP-mediated DNA recombination. USP21+/ mice were inter-
crossed to generate USP21/ and WT littermates. USP21/ mice were 
backcrossed for five generations to the C57BL/6 background. Age-matched 
WT and USP21/ littermates were used for all experiments. The following 
primers were used for genotyping mouse USP21 allele: P1, 5-AGAATT-
CTTCCTTGGGTCCT-3; P2, 5-GTCATCCTACCTCACTGGTC-3; 
P-LOX, 5-AGGTGGATCCATCATATGAGA-3; P3, 5-CTAGGCTG-
CTTGCAGTTGGA-3; P4, 5-GTGGCTAGAAAATCTCTAGG-3. The 
following primers were used for genotyping Cre transgenic allele: CreMice-
COM-5, 5-GGGACCACCTTCTTTTGGCTTC-3; CreMice-WT-3, 
5-AAGATGTGGAGAGTTCGGGGTAG-3; CreMice-MUT-3, 5-CCA-
GATCCTCCTCAGAAATCAGC-3. The following primers were used for 
RT-PCR analysis of USP21 expression: mUSP21-RT-5, 5-GCTCACCA-
CACACTGCTTCT-3; mUSP21-RT-3, 5-GGATTCACAGCTTCA-
CAGGA-3. All animal experiments were performed in accordance with 
protocols approved by the Institutional Animal Care and Use Committee 
of Baylor College of Medicine.
BM reconstitution in SCID mice. The Rag1/severe complex immune 
deficiency (SCID) mice (The Jackson Laboratory), ages 8–12 wk, were bred 
and maintained in a specific pathogen–free animal facility. BM cells from 
8-wk-old WT and USP21/ mice were isolated from femoral bones. 
A total of 50 million BM cells per mouse were intravenously injected into 
lethally irradiated (500 cGy) 10-wk-old SCID mice. Success of transplanta-
tion was confirmed by flow cytometry analysis using PE-labeled anti-CD4 
and APC-Cy7–labeled anti-CD8 antibodies after 10 wk of transplantation. 
BM chimeras were further infected with VSV at different doses. Spleens from 
these chimeras were analyzed 10 wk after transplantation.
Isolation of MEFs, PMs, BMDCs, and BMMs. WT and USP21/ 
MEFs were prepared from day 13.5 embryos and cultured in DMEM supple-
mented with 10% FBS. A20/, TAXBP1/, and ITCH/ MEFs were 
provided by A. Ma (University of California, San Francisco, CA), E.W. Harhaj 
(Johns Hopkins School of Medicine, Baltimore, MD), and L. Matesic (Uni-
versity of South Carolina, Columbia, SC), respectively. PMs were harvested 
by flushing peritoneal cavities from 8-wk-old mice. BMDCs and BMMs 
were generated by flushing BM cells from femurs and tibiae of mice. Cells 
were cultured in M-CSF or GM-CSF/IL-4 conditional media for 7 d to 
generate BMMs and BMDCs respectively.
Reagents and antibodies. Mouse monoclonal antibodies against MYC 
(sc-40), HA (sc-7392), and Ub (sc-8017), rabbit polyclonal antibodies against 
RNF135 (sc-102092) and IRF3 (sc-9082), and protein A–agarose were from 
Santa Cruz. Mouse monoclonal antibodies against -actin (A2228) and 
FLAG (F3165) were from Sigma-Aldrich. Rabbit monoclonal antibodies 
against RIG-I (3743) and p-IRF3 (4947), rabbit antibodies against phospho-
IKK/ (2078S), and IKK (2684S) were obtained from Cell Signaling 
Technology. Mouse monoclonal antibodies against RIG-I (ALX-804-849) 
were purchased from Enzo Life Science. Anti-Sendai virus (PD029) antibod-
ies were obtained from Medical and Biological Laboratories. Texas Red– 
labeled anti–mouse antibodies (T862), Oregon Green labeled anti–rabbit 
antibodies (P36930), and anti-Ubc13 antibodies (371100) were purchased 
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fluorescently conjugated secondary antibodies for 1 h at room temperature, 
and followed by blue nuclear counterstaining with Hoechst. Coverslips were 
mounted and observed with an Olympus Fluoview FV 1000 Laser Scan 
Confocal Microscope.
In vitro deubiquitination assay. MYC-USP21-WT, MYC-USP21-
C221A, MYC-CYLD, or MYC-A20 proteins were expressed in HEK293T 
cells and immunoprecipitated by MYC antibodies. To perform in vitro deu-
biquitination assay, FLAG-RIG-I-CARD expression vectors were trans-
fected into HEK293T cells with the vectors encoding HA-Ub. Cells were 
lysed in the lysis buffer only with PMSF as a protease inhibitor and centri-
fuged at 15,000 g for 15 min. Supernatant containing polyubiquitinated 
FLAG-RIG-I-CARD proteins in the cell lysates were co-incubated with 
the immunoprecipitated MYC-USP21 WT or C221A mutant for 2 h at 
30°C. After reaction, 0.1% SDS would be added and FLAG-RIG-I-CARD 
proteins in the supernatant were immunoprecipitated with anti-FLAG anti-
bodies and immunoblotted with anti-HA antibodies to detect the presence 
of ubiquitinated FLAG-RIG-I-CARD.
Viruses. SeV was purchased from Charles River. VSV and VSV-eGFP were 
gifts from G. Barber (University of Miami. Miami, FL). VSV was generated 
and titrated on baby hamster kidney (BHK21) cells or Vero cells, respectively. 
In brief, BHK21 cells were infected with VSV until >70% of cells exhibited 
clear cytopathic effects. Cell supernatant was harvested and separated into ali-
quots at 80°C. To titer VSV, Vero cells were seeded into a 6-well plate at 
8 × 105 cells per well. At the next day, serial dilutions of the stocked virus 
were made in DMEM without serum. Diluted virus suspension was then 
added to Vero cells. After 1 h of incubation at 37°C, viruses were removed. 
Subsequently, wells were overlaid with 2 ml of growth medium with 1% of 
low-melting agarose and incubated at 37°C for 10 d. The viral titer was esti-
mated by counting the plaque number.
Viral infection in mice and measurement of IFN production. Mice 
of different genotypes were infected with VSV via intraperitoneal or tail vein 
injection. Sera were collected at different time points for measuring IFN induc-
tion by ELISA according to the manufacturer’s instructions. ELISA kits for 
mouse IFN- and IFN- were purchased from PBL Biomedical Laboratories.
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